Your Cart ()
cload

GUARANTEED SAFE & SECURE CHECKOUT

Free Shipping on All Orders Over $65

Are Peptides Safe for Dogs? The Cancer Caution, the Supply Problem, and What No Study Has Checked

October 15, 2026

Veterinarian examining a senior golden retriever beside a HempMy Pet hemp oil bottle and a peptide vial, for an article on peptide safety in dogs

Written by Marc Brannigan, Co-Founder & CEO of HempMy Pet. Last updated 15 October 2026.

The short answer: Nobody can say, because no controlled safety trial of BPC-157, TB-500, KPV or GHK-Cu has been run in dogs. What exists: a 28-day beagle study of BPC-157 with no apparent changes, a pharmacokinetic study reporting good tolerance, and a decade of uncontrolled case series with no serious adverse events. What is missing: interaction data, long-term data, data in sick or old dogs. The three real risks are a theoretical cancer caution, an unregulated supply, and dosing a dog in micrograms from a vial nobody checked.

"Are peptides safe for dogs" is one of Google's own suggested questions on every peptide search, and the pages answering it are mostly written by sellers. This is the known-unknowns version: what has been checked, what has not, and the three risks that do not depend on the molecule working at all.

What Has Actually Been Checked in Dogs

Peptide Dog safety data Not checked
BPC-157 28-day beagle study at 0.1, 0.5 and 2 mg/kg a day by injection: no apparent changes versus saline (2025 BPC-157 literature review). A 2022 pharmacokinetic study in beagles: well tolerated, linear kinetics, rapid clearance. Long-term use. Sick, old or polypharmacy dogs. Any drug interaction. Any dog with a tumour.
TB-500 None. Everything. Evidence is cell/animal mechanism and racehorse-trainer experience.
KPV None. Two mouse colitis models. Everything in dogs or cats.
GHK-Cu None. Human and cell wound-healing data. Everything; copper clears through the liver, so hepatic disease is a specific concern.
Oral collagen peptides A double-blind placebo-controlled trial in 31 dogs — food-grade, no safety signal — (a different product that shares the word)

The chief veterinary officer of the North American Veterinary Community told Forbes this week that the studies are "very, very rudimentary," that some peptides marketed to pet owners have barely been through safety studies, and that her biggest concern is dosing: like insulin, a peptide dosed wrong goes from doing nothing to causing an emergency.

Risk 1: The Cancer Caution

The caution that matters most: cancer. BPC-157 and TB-500 work partly by growing new blood vessels, and a tumour needs new blood vessels to grow. No study has shown either peptide causes or accelerates cancer in a dog — and most vets who use them still refuse to give them to any dog with a known or suspected mass. The AVMA puts the lifetime risk at about 1 in 4 dogs, rising to 1 in 2 for dogs 10 and older, which is exactly the senior population these are marketed to. A new lump, unexplained weight loss or a sudden decline is a stop-and-get-it-checked, not a reason to start a peptide.

The practical rule most vets who use these peptides apply: no angiogenic peptide in a dog with a known or suspected mass, a lump check before starting any senior, and stop-and-investigate if a new lump, unexplained weight loss or sudden decline appears during a protocol.

Risk 2: The Supply

Most peptides given to dogs come from "research use only" vendors, and that label is the vendor's legal shield, not a quality standard. Nobody checks that the vial matches the label. Impurities were FDA's stated reason for placing BPC-157 and TB-500 on its Category 2 list in 2023, and the agency sent warning letters to companies marketing unapproved peptides in August 2026. Add sterility — a home-reconstituted vial drawn through a used stopper over weeks is an infection risk — and dilution: a small dog's dose from a concentrated vial is a few units on an insulin syringe, which is where measurement errors happen. A compounding pharmacy on a vet's order solves all three.

Want a vet to check your dog before you decide?

Tell us the dog, the problem, what has been ruled out and what the dog is taking. A vet on our team tells you plainly whether a peptide protocol is reasonable, or whether a workup comes first.

Free, no purchase. We review every submission and reply by email within 48 hours; we may text if you leave a number. No spam, unsubscribe any time. Privacy. General guidance, not a diagnosis; any peptide protocol is prescribed and dispensed by a licensed veterinarian.

Got it — thank you.

We'll review your dog's details and reply by email within 48 hours. If a vet needs more — bloodwork dates, imaging, a current medication list — the email will say exactly what.

Risk 3: Interactions and the Wrong-Diagnosis Trap

The dogs these peptides are marketed to are seniors — which means NSAIDs, often gabapentin, sometimes heart, thyroid or kidney medication, sometimes Librela or prednisone. No study has mapped how BPC-157 or TB-500 interact with any of them. And the symptoms owners try to treat with a repair peptide — stiffness, a limp, gut upset, low appetite, a general decline — are also the presenting signs of diagnosable disease, including the ones that kill dogs quietly. A peptide given before a workup can delay the finding that changes the outcome. This is the risk no vendor page mentions, and the one a vet is for.

Legality, briefly. There is no FDA-approved BPC-157, TB-500 or KPV product for animals. The lawful route is a licensed veterinarian ordering a compounded preparation under FDA's Guidance for Industry #256, which covers non-food animals, on a vet's order, when no approved option works. FDA's advisory committee voted 8–6 in July 2026 to recommend BPC-157, KPV, TB-500 and MOTS-c for human compounding; the vote is not binding and FDA has not acted. A research-only vial bought online and injected without a vet sits outside all of it. The full timeline is in Peptides for Dogs.

Signs to Stop and Call the Vet

  • A new lump anywhere, or an existing one that changes
  • Unexplained weight loss, or a drop in appetite that lasts more than a couple of days
  • Vomiting, diarrhoea or black stool that starts after dosing begins
  • Swelling, heat or discharge at an injection site
  • Lethargy, wobbliness, or a sudden worsening of the thing you were treating
  • Increased thirst or urination — kidney and liver signals in a senior

Compared Honestly to Hemp

Hemp's canine safety record is not spotless and we publish it: five published trials, liver-enzyme (ALKP) rises reported in three of them, no serious adverse events, and a real interaction caution because CBD shares liver enzymes with many prescription drugs. The difference is that those are known risks you can monitor with a blood panel. The peptide risks are unknowns. Known and monitorable beats unknown. The full accounting is in Hemp & CBD Side Effects in Dogs.

The known, monitorable daily layer — legal, oral, five canine trials

Grown on our own certified-organic Colorado farm, formulated in-house, third-party tested every batch. Serving by weight →

If your dog takes any prescription medication, talk to your vet before adding hemp, because it can change how quickly the body clears other drugs. We cover that, and the published safety findings, in hemp and CBD side effects in dogs.

The One-Line Version

A peptide can be a reasonable, vet-supervised adjunct for a diagnosed problem in a dog that has been checked for masses, with the full medication list on the table and a compounded preparation at a verified concentration. The same molecule from a research vial, injected at home into an undiagnosed senior, is three unmanaged risks stacked on top of a treatment nobody has tested. The molecule is the same. The safety is not.

Frequently Asked Questions

Can you give dogs BPC-157?

Legally, only through a licensed veterinarian ordering a compounded preparation under FDA's animal-compounding guidance. Practically, it has a 28-day beagle safety study and a pharmacokinetic study behind it, no controlled efficacy trial, and a cancer caution that rules it out for any dog with a known or suspected mass.

What peptides are safe for dogs?

None of the injectables has a controlled safety trial in dogs. BPC-157 has the most data (a beagle safety study, a PK study, case series); TB-500, KPV and GHK-Cu have none in dogs. Oral collagen peptides are food-grade and safe. Safety in a given dog is a vet's decision, and the angiogenesis caution applies to BPC-157 and TB-500.

What's the bad side of peptides?

Three things that do not depend on whether they work: they promote blood-vessel growth, which is a theoretical risk in any dog with a tumour; the supply is unregulated, so purity and dose vary between vendors and batches; and they are dosed in micrograms from a vial, which is where mistakes happen. Plus no interaction data with the drugs senior dogs are usually on.

What is the silent killer of dogs?

Usually cancer, bloat, heart disease or kidney disease — conditions that progress without obvious signs. It is the right question to ask before a peptide: about 1 in 2 dogs over 10 develops cancer, and the symptoms owners try to treat with a peptide are often the first signs of something that needs a workup.

Are peptides safe for older dogs?

Older dogs are the most common candidates and the highest-risk group at once: more likely to have an undiagnosed mass, more likely to be on several medications with no interaction data, more likely to have reduced kidney or liver function. Baseline bloodwork, a lump check and a vet-set dose are the minimum.

Can peptides cause cancer in dogs?

No study has shown that BPC-157 or TB-500 causes or accelerates cancer in a dog. The caution is mechanistic — they promote the blood-vessel growth a tumour needs — and it is why vets avoid them in any dog with a known or suspected mass.

Is it legal to give my dog peptides?

There is no FDA-approved product. A licensed vet may order a compounded preparation under GFI #256 for a non-food animal when no approved option works. A research vial bought online and injected without a vet is outside that framework; legality turns on who directs the treatment and how the drug is sourced.

Is hemp safer than peptides for dogs?

Hemp's risks are known and published — liver-enzyme rises in three of five canine trials, drug interactions — and can be monitored with bloodwork. Peptide risks in dogs are unknown because the trials have not been run. Known and monitorable is the safer position for daily use; a peptide is a vet-supervised, time-limited protocol for a defined problem.

Still weighing it?

Two minutes, no purchase. A vet reviews your dog's situation and tells you what the safe next step actually is.

Free, no purchase. We review every submission and reply by email within 48 hours; we may text if you leave a number. No spam, unsubscribe any time. Privacy. General guidance, not a diagnosis; any peptide protocol is prescribed and dispensed by a licensed veterinarian.

Got it — thank you.

We'll review your dog's details and reply by email within 48 hours. If a vet needs more — bloodwork dates, imaging, a current medication list — the email will say exactly what.

About this article
Marc Brannigan
Co-Founder & CEO, HempMy Pet

Marc co-founded HempMy Pet in 2016 with his business partner Natalie Mondine, the company's COO. They were making the hemp oil for people first and bottled it for pets — one of the first CBD products made for pets. HempMy Pet breeds its own hemp genetics, grows them on its certified-organic Colorado farm, and formulates every batch in-house under human-grade standards — seed to sale, nothing sourced overseas. Every batch is third-party tested and the certificates of analysis are published. More about us.

The research behind our joint claims
90-day trial · Colorado State University

HempMy Pet ran its own 90-day study of 37 dogs with chronic joint discomfort. Of the 32 that completed it, 30 (93%) showed a benefit, and 94% of owners reported their dog's quality of life had improved. It was overseen by Dr. Robin Downing, DVM, MS of the Downing Center for Animal Pain Management, with Lori Kogan, Ph.D. and Peter W. Hellyer, DVM of Colorado State University's College of Veterinary Medicine & Biomedical Sciences, and published in the Journal of the American Holistic Veterinary Medical Association. Read the methodology.

Why Dr. Downing: in 2005 she became only the third veterinarian in the world credentialed as a Diplomate of the American Academy of Pain Management. She founded the International Veterinary Academy of Pain Management, is a Diplomate of the ACVSMR, a Certified Veterinary Pain Practitioner and a Certified Canine Rehabilitation Practitioner, and was the AVMA's 2020 Bustad Companion Animal Veterinarian of the Year. Chronic joint pain is her life's work. Read the published paper (PDF).

This article is general information for dog owners, not veterinary advice. It is reviewed and updated as new peer-reviewed evidence is published, and where the evidence is thin or negative we say so.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This article is general information, not veterinary advice. If your dog is unwell, contact your veterinarian.


← Older Post Newer Post →

From the brand behind this article

Backed by Two University Clinical Trials

HempMy Pet is one of the only pet hemp brands with real university research behind its full-spectrum oil — grown on our own Colorado farm since 2015.

93%+ of dogs in the study showed a benefit
94% of owners reported improved quality of life
2 university clinical trials — Colorado State & Tarleton State